N@N

Somaxon Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference

  //health-fitness.news-articles.net/content/2009/ .. the-11th-annual-bio-ceo-investor-conference.html
  Published in Health and Fitness on Wednesday, February 4th 2009 at 5:12 GMT, Last Modified on 2009-02-04 05:12:33 by Market Wire

SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced that Richard Pascoe, president and chief executive officer, will present a company overview at the 11^th Annual BIO CEO & Investor Conference at the Waldorf-Astoria in New York City on Monday, February 9, 2009, at 12:45 p.m. PT (3:45 p.m. ET).

A live webcast of the presentation will be available in the Investor Relations section of the company's website under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for at least 14 days.

About Somaxon Pharmaceuticals

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. A New Drug Application (NDA) for Silenor^® (doxepin), Somaxon's drug candidate for insomnia, has been filed with the U.S. Food and Drug Administration and currently is under review.

For more information, please visit the company's web site at [ www.somaxon.com ].